Results 141 to 150 of about 31,333 (185)

The Clinical Role of CXCR4-Targeted PET on Lymphoproliferative Disorders: A Systematic Review. [PDF]

J Clin Med
Zamanian M, Albano D, Treglia G, Rizzo A, Abedi I.   +4 more
europepmc   +1 more source

Beyond Chemotherapy: Present and Future Perspectives in the Treatment of Lymphoproliferative Disorders. [PDF]

Biomedicines
Massaro F, Andreozzi F, Abrassart T, Castiaux J, Massa H, Rizzo O, Vercruyssen M.   +6 more
europepmc   +1 more source

Impact of antiviral prophylaxis on EBV viremia and posttransplant lymphoproliferative disorders in solid organ transplant recipients: a systematic review and meta-analysis. [PDF]

Virol J
Moghadamnia M, Delroba K, Heidari S, Rezaie Z, Dashti-Khavidaki S.   +4 more
europepmc   +1 more source

Limited utility of Epstein-Barr virus (EBV) surveillance for predicting post-transplant lymphoproliferative disorders in adult EBV seropositive lung transplant recipients. [PDF]

J Clin Virol
Mah JK, Tam PCK, Chang YC, Saullo JH, Baker AW, Maziarz EK, Messina JA, Sim B, Abusalem L, Hanna S, Pipeling MR, Snyder LD, Reynolds JM, Wolfe CR, Lee MJ, Alexander BD, Heldman MR.   +16 more
europepmc   +1 more source

Analysis of Notch1 protein expression in methotrexate-associated lymphoproliferative disorders. [PDF]

J Clin Exp Hematop
Okatani T, Nishimura MF, Egusa Y, Yoshida S, Nishimura Y, Nishikori A, Yoshino T, Yamamoto H, Sato Y.   +8 more
europepmc   +1 more source

SLAM Family Receptors in B Cell Chronic Lymphoproliferative Disorders. [PDF]

Int J Mol Sci
Kľoc D, Kurhajec S, Huniadi M, Sýkora J, Guman T, Šarišský M.   +5 more
europepmc   +1 more source

CAD204520 Targets NOTCH1 PEST Domain Mutations in Lymphoproliferative Disorders. [PDF]

Int J Mol Sci
Pagliaro L, Cerretani E, Vento F, Montanaro A, Moron Dalla Tor L, Simoncini E, Giaimo M, Gherli A, Zamponi R, Tartaglione I, Lorusso B, Scita M, Russo F, Sammarelli G, Todaro G, Silini EM, Rigolin GM, Quaini F, Cuneo A, Roti G.   +19 more
europepmc   +1 more source

Interventional treatment of refractory non-traumatic chylous effusions in patients with lymphoproliferative disorders. [PDF]

Clin Exp Med
Wagenpfeil J, Hoß K, Henkel A, Kütting D, Luetkens JA, Feldmann G, Brossart P, Attenberger UI, Pieper CC.   +8 more
europepmc   +1 more source

Integration of CD200, CD43 and ROR1 in Multiparameter Flow Cytometry (MFC) Routine Panels for the Differential Diagnosis of B-cell lymphoproliferative Disorders (B-LPDs). [PDF]

Mediterr J Hematol Infect Dis
Laganà A, Maglione R, Costa A, Mandelli B, Bisegna ML, Milani ML, Filipponi V, Nardacci MG, Soriano T, Santacroce E, Petrucci L, Giordano C, Martelli M, De Propris MS.   +13 more
europepmc   +1 more source

The potential of 3rd-generation nanopore sequencing for B-cell clonotyping in lymphoproliferative disorders. [PDF]

EJHaem
Hansen MH, Cédile O, Abildgaard N, Nyvold CG.   +3 more
europepmc   +1 more source